Addressing the risk of bacterial contamination of platelets within the United States: A history to help illuminate the future

Transfusion

Volumn 53, Issue 1, 2013, Pages 221-231

  Brecher, Mark E ^a   Blajchman, Morris A ^a   Yomtovian, Roslyn ^a   Ness, Paul ^a   Aubuchon, James P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; BACTERIUM CONTAMINATION; BLOOD BANK; BLOOD COMPONENT; BLOOD TRANSFUSION; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; PATIENT SAFETY; THROMBOCYTE; UNITED STATES;

BACTERIA; BLOOD PLATELETS; DISINFECTION; FEMALE; HUMANS; MALE; PLATELET TRANSFUSION; PLATELETPHERESIS; SKIN;

EID: 84872271932     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03708.x     Document Type: Note

References (38)

1. Tomasulo P, Su L,. Is it time for new initiatives in the blood center and/or the hospital to reduce bacterial risk of platelets ? Transfusion 2011; 51: 2527-33.
2. Alter HJ,. Pathogen reduction: a precautionary principle paradigm. Transfus Med Rev 2008; 22: 97-102.
3. AABB receives open letter to blood collection community (August 16, 2002). AABB Wkly Rep 2002; 8: 5.
4. Brecher ME, Yomtovian R, Blajchman MA, AuBuchon J, Ness PM,. Open letter to the blood collection community. ABC Newsl 2002; 33: 18.
5. CBBS Website. California Blood Bank Society, e-network forum. 2002. [cited 2011 Nov 28]. Available from: URL: http://www.cbbsweb.org/enf/2002/ plttxsepsisltr.pdf and http://www.cbbsweb.org/enf/2002/plttxsepsisltrp2.html
6. Gladwell M,. The tipping point. How little things can make a big difference. New York: Back Bay Books/Little Brown and Company; 2002.
7. Yomtovian R,. Bacterial contamination of blood: lessons from the past and road map for the future. Transfusion 2004; 44: 450-60.
8. Fratantoni J,. Comments at FDA Blood Products Advisory Committee meeting. Rockville (MD): CBER Office of Communication, Training, and Manufacturers Assistance; 1986.
9. Blood Products Advisory Committee. Review of data supporting extension of dating period for platelets. Washington (DC): FDA; 2002, Mar 15. [cited 2011 Nov 28]. Available from: URL: http://www.fda.gov/OHRMS/DOCKETS/ac/02/briefing/ 3839b2-02-platelets.pdf
10. Esber EC,. Reduction of the maximum platelet storage period to 5 days in an approved container. Memo to all registered blood establishments. Bethesda (MD): FDA; 1986, Jun 2. [cited 2011 Feb 17]. Available from: URL: http://www.fda.gov/./OtherRecommendationsforManufacturers/ MemorandumtoBloodEstablishments/UCM063013.pdf
11. Goldman M, Blajchman M,. Blood product-associated bacterial sepsis. Transfus Med Rev 1991; 5: 73-83.
12. Stoto MA,. Presentation at the Committee on Labor and Human Resources, United States Senate on HIV and the blood supply: an analysis of crisis decision making. Washington (DC): National Academy of Science; October, 1997 [cited 2011 Nov 28]. Available from: URL: http://www7.nationalacademies.org/ocga/testimony/ Aid%20HIV.asp
13. Leveton LB, Sox HC Jr, Stoto MA,. Executive Summary: HIV & the blood supply: an analysis of crisis decision making. 1995. [cited 2011 Nov 28]. Available from: URL: http://www.aegis.com/law/journals/1995/IOM95071.html
14. US Food and Drug Administration. Blood Products Advisory Committee Transcripts, Center for Biologist Evaluation and Research, 36th meeting. May 29, 1992, Rockville MD. (Transcripts available from the FDA, Freedom of Information staff upon request.)
15. Klein HG, Dodd RY, Ness PM, Fratantoni JA, Nemo GJ,. Current status of microbial contamination of blood components: summary of a conference. Transfusion 1997; 37: 95-101.
16. US Department of Health and Human Services, Food and Drug Administration, and Center for Biologist Evaluation and Research. Bacterial Contamination of Platelets Workshop. September 24, 1999, Bethesda, MD. [cited 2006 Jun 27]. Available from: URL: http://www.fda.gov/cber/minutes/bact092499.pdf
17. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR,. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41: 1493-99.
18. Jacobs MR, Good CE, Lazarus HM, Yomtovian RA,. Relationship between bacterial load, species, virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008; 46: 1214-20.
19. Yomtovian RA, Palavecino EL, Dykstra AH, Downes KA, Morrissey AM, Bajaksouzian S, Pokorny MA, Lazarus HM, Jacobs MR,. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion 2006; 46: 719-30.
20. AuBuchon JP, Cooper LK, Leach MF, Zuaro DE, Schwartzman JD,. Experience with universal bacterial culturing to detect contamination of apheresis platelet units in a hospital transfusion service. Transfusion 2002; 42: 855-61.
21. Brecher ME, Hay SN, Rothenberg SJ,. Monitoring apheresis platelet bacterial contamination with the BacT/Alert 3D-a university experience. Transfusion 2003; 43: 974-8.
22. Food and Drug Administration. Safety and efficacy of methods for reducing pathogens in cellular blood products used in transfusion. Rockville (MD): CBER Office of Communication, Training and Manufacturers Assistance; 2002, Aug 7-8. [cited 2006 Jun 26]. Available from: URL: http://www.fda.gov/cber/minutes/ pathtrans080802.pdf
23. Nakhasi HL,. BacT/ALERT culture bottles, bioMérieux, Durham, NC. 510(k) Summary, prepared 2/15/2002. 2002. [cited 2012 Apr 26]. Available from: URL: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ ApprovedProducts/SubstantiallyEquivalent510kDeviceInformation/UCM070896.pdf
24. Golding B,. Pall BDS, Medsep Corporation, Covina, CA. 510(k) Summary, prepared 8/21/2002. 2002. [cited 2012 Apr 26]. Available from: URL: http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/ SubstantiallyEquivalent510kDeviceInformation/ucm081062.htm
25. Shulman IA,. College of American Pathologists Laboratory Accreditation checklist item TRM.44955. Phase I requirement on bacterial detection in platelets. Arch Pathol Lab Med 2004; 128: 958-63.
26. Fridey J, editor. Standards for blood banks and transfusion services. 22nd ed. Bethesda (MD): American Association of Blood Banks; 2003.
27. US Department of Health and Human Services. Advisory Committee of Blood Safety and Availability. Washington, DC: US Department of Health and Human Services. 2004, April 7-8. [cited 2006 Jun 26]. Available from: URL: http://www.hhs.gov/bloodsafety/transcripts/04-07-04.pdf
28. Silva MA, Gregory KR, Carr-Greer MA, Holmberg JA, Kuehnert MJ, Brecher ME,. Summary of the AABB interorganizational task force on bacterial contamination of platelets: fall 2004 impact survey. Transfusion 2006; 46: 636-41.
29. Ness P, Braine H, King K, Barrasso C, Kickler T, Fuller A, Blades N,. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001; 41: 857-61.
30. Fuller AK, Uglik KM, Savage WJ, Ness PM, King KE,. Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets. Transfusion 2009; 49: 2588-93.
31. Fang CT, Chambers LA, Kennedy J, Strupp A, Fucci MC, Janas JA, Tang Y, Hapip CA, Lawrence TB, Dodd RY,. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005; 45: 1845-52.
32. Yomtovian R, Tomasulo P, Jacobs MR,. Platelet bacterial contamination: assessing progress and identifying quandaries in a rapidly evolving field. Transfusion 2007; 47: 1340-46.
33. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ,. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007; 47: 1134-42.
34. US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2010. 2011. [cited 2012 Apr 26]. Available from: URL: http://www.fda.gov/downloads/ BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/ TransfusionDonationFatalities/UCM254860.pdf
35. Jacobs MR, Smith D, Heaton WA, Zantek ND, Good CE,. Detection of bacterial contamination in prestorage culture negative apheresis platelets on day of issue with the PGD test. Transfusion 2011; 51: 2573-82.
36. Olthuis H, Puylaert C, Verhagen C, Valk L,. Method for removal of contamination bacteria during venepuncture. Presented at the 5th International Society of Blood Transfusion Regional Congress, Venice, Italy July 2-5, 1995.
37. McDonald CP, Roy A, Mahajan P, Smith R, Charlett A, Barbara JA,. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004; 86: 178-82.
38. McDonald C, Colvin J, Biggs C, Goodhand K, Harden G, McGuane S,. Do diversion and improved donor arm disinfection reduce bacterial contamination in platelet concentrates ? Transfusion 2005; 45: 56A.